About

 

The Association for the Cannabinoid Industry (ACI) is a membership organisation for businesses committed to nurturing a safe, legal and flourishing commercial cannabis extract market in the UK and Europe.

Our vision is to create an innovative and ethical sector with the highest standards of product quality, consumer satisfaction and regulatory compliance. All our members sign up to our quality charter.

We deliver vital stewardship for this emerging sector through constructive engagement with key stakeholders and thought leaders. To find out what we’ve achieved see our list of milestones.

Our team of scientific, regulatory and industry leaders provide expert support and guidance to our members.

ACI in the Media

[Pharmacy Business Magazine] Industry body welcomes FSA update on CBD products

Pharmacy Business Magazine reports that the FSA updated the criteria for CBD products which can remain on sale from 1 April 2021. Previously, only products which were on sale at the time of the FSA’s announcement (13 February 2020) and were linked to an application which had been validated by 31 March 2021 were to be included.